PULMONX CORPORATION (LUNG) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 37.43M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 114.73M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $37.43M | (m) | (m) | $114.73M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $37.21M | (m) | (m) | $119.97M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $36.99M | (m) | (m) | $129.29M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $37.02M | (m) | (m) | $138.28M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $37.01M | (m) | (m) | $147.19M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $29.39M | (m) | (m) | $150.74M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $34.00M | (m) | (m) | $162.85M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $37.14M | (m) | (m) | $167.40M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $37.11M | (m) | (m) | $172.63M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $32.00M | (m) | (m) | $164.58M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $35.09M | (m) | (m) | $177.78M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $37.15M | (m) | (m) | $185.02M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $37.15M | (m) | $135.15M | $193.11M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $37.17M | (m) | $152.84M | $201.27M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $17.23M | (m) | $141.14M | $193.68M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $12.34M | (m) | $156.90M | $202.20M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $14.46M | (m) | $162.09M | $212.73M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $16.63M | (m) | $170.08M | $222.85M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $17.32M | (m) | $180.04M | $235.17M | (m) |
| 2021-09-30 | (m) | (m) | $3.31M | (m) | (m) | $199.85M | $246.82M | (m) |
| 2021-06-30 | (m) | (m) | $1.89M | (m) | (m) | $209.48M | $248.94M | (m) |
| 2021-03-31 | (m) | (m) | $472.00K | (m) | (m) | $219.07M | $255.27M | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | (m) | (m) | $231.56M | $263.71M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |